CDK4/6 inhibitors like abemaciclib and ribociclib improve invasive disease-free survival in breast cancer trials, but controversy surrounds study designs, bias, and cost-effectiveness, raising ...
Remember that the intentions can be teeny tiny, and the list doesn’t have to be long at all. If there are a few things you feel really good about, stop there! An unwieldy list can feel overwhelming, ...